Posts

“How Long Have I Got?” in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question

Image
early symptoms of non small cell lung cancer :: Article Creator Non-Small Cell Lung Cancer Ryan Nguyen, DO, University of Illinois Chicago, highlights the importance of personalized care for patients who have non–small cell lung cancer (NSCLC) and the potential of artificial intelligence (AI) in oncology, while cautioning against its limitations, including the risk of unsupported recommendations. Non-small-cell Lung Cancer Articles From Across Nature Portfolio Developing multiple EGFR-mutant lung cancers The occurrence of multiple independent tumours in patients with EGFR-mutant lung cancer was unexplained. A recent study in Nature Cancer identified distinct genetic predisposition mechanisms, including developmental mosaicism and germline EGFR variants, that contribute to the formation of multiple primary tumours. How Accurate Is Liquid Biopsy In Diagnosing Lung Cancer? Many advancements have happened in the medical field that work toward...

What to Know About Stage 3 Non-Small Cell Lung Cancer

Image
small cell lung cancer nhs :: Article Creator Lung Cancer Drug Already Available On NHS Could Cut Bladder Deaths Access Denied You don't have permission to access "http://www.Telegraph.Co.Uk/news/2025/01/13/lung-cancer-drug-available-nhs-cut-bladder-deaths/" on this server. Reference #18.6924c317.1737073519.2a16bf06 https://errors.Edgesuite.Net/18.6924c317.1737073519.2a16bf06 Treatment For Lung Cancer Treatment for lung cancer includes surgery, chemotherapy, radiotherapy, immunotherapy and other targeted therapy drugs. People may be offered one or more different treatments depending on the stage and type of lung cancer as well as their general health. Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 87% of cases. NSCLCs can be broken down into 2 major sub-types: adenocarcinoma (sometimes referred to as non-squamous) and squamous cell carcinoma. With recent advances in scient...

How long does small cell lung cancer stay in remission?

Image
types of pulmonary emphysema :: Article Creator COPD News Mar. 10, 2023 — One in 10 adults suffer from the debilitating effects of chronic obstructive pulmonary disease (COPD). Research around a new breathing device developed by pulmonologists offers promise for improving ... Dec. 21, 2022 — Researchers have genetically profiled nearly 200,000 cells from lungs, mapping their precise locations in tissue to discover an unexpected new immune niche in our ... Dec. 5, 2022 — A six-month study oncludes that the use of portable home air purifiers can improve some markers of cardiovascular health in people with chronic obstructive pulmonary disease, or ... Nov. 23, 2022 — Sometimes healthcare professionals treat patients with opioids such as morphine to relieve symptoms, but there has been a lack of evidence as to whether this helps with severe chronic breathlessness. ... Nov. 15, 2022 — Airway inflammation and emphysema are more common in...

Non-Small Cell Lung Cancer (NSCLC) Treatment & Management

Image
benign brain tumor surgery recovery :: Article Creator The Masked Singer's Davina McCall Has Come To 'major Career Decision' After Brain Tumour Operation Davina McCall has been recovering after undergoing surgery to remove a benign brain tumour and sources say the health scare has made her reconsider her career and life choices ( Image: Getty Images for BAFTA) Davina McCall has experienced a life-altering "realisation" following her recent health scare. At 57, after undergoing surgery to remove a benign brain tumour, the beloved TV personality is in recovery. The Masked Singer star had to confront a colloid cyst in her brain that was around "14 mm wide" and needed urgent removal. Now almost two months on from the scare, Davina is healing well. Her partner Michael Douglas, 49, last month gave an update that Davina was planning to ease back into work by mid-January. Making her first public appearanc...

Small Cell Lung Cancer (SCLC): Practice Essentials, Pathophysiology, Etiology

Image
adenocarcinoma lung pathology outlines :: Article Creator

Small Cell Lung Cancer (SCLC): Practice Essentials, Pathophysiology, Etiology

Image
asbestos related lung cancer :: Article Creator Global Trends In Lung Cancer Deaths Highlight Persistent Air Pollution Risks A recent study reveals that while deaths from lung and related cancers have decreased in the world's 10 most populous countries between 1990 and 2019, major challenges remain. These challenges, linked to tobacco use, air pollution, and asbestos exposure, call for continued public health efforts and further research. The findings, published in eClinicalMedicine, were based on data from the Global Burden of Disease database and led by researchers from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Over the 30-year period, there was an 8% overall decrease in deaths caused by tracheal, bronchial, and lung (TBL) cancers. Tobacco-related deaths declined slightly but still accounted for the majority of cases. Meanwhile, deaths linked to air pollution and asbestos exposure...

Non-Small Cell Lung Cancer (NSCLC) Treatment & Management

Image
3 a lung cancer :: Article Creator Top Lung Cancer Stories In 2024 CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines. Text Top Stories typed on retro typewriter: © MP Studio - stock.Adobe.Com Throughout 2024, CURE covered a variety of stories in the lung cancer space, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). We compiled a list of the top stories in lung cancer, some of which focus on new treatment strategies like cancer vaccines. Lower Keytruda Doses May Be as Effective as Standard Doses for Stage 4 NSCLC Study findings have indicated that one-year survival rates were comparable in patients with stage 4 NSCLC receiving either a standard or reduced dose of Keytruda (pembrolizumab), thereby justifying continued enrollment in the NVALT-30 trial. The study found no significant difference in overall survival between treatment...